Literature DB >> 11396555

The effect of exposure to 35,000 ft on incidence of altitude decompression sickness.

J T Webb1, K M Krause, A A Pilmanis, M D Fischer, N Kannan.   

Abstract

INTRODUCTION: Exposure to 35,000 ft without preoxygenation (breathing 100% oxygen prior to decompression) can result in severe decompression sickness (DCS). Exercise while decompressed increases the incidence and severity of symptoms. Clarification of the level of activity vs. time to symptom onset is needed to refine recommendations for current operations requiring 35,000-ft exposures. Currently, the U.S. Air Force limits these operations to 30 min following 75 min of preoxygenation. The objective of this study was to determine the effect of exercise intensity on DCS incidence and severity at 35,000 ft.
METHODS: Following 75 or 90 min of ground-level preoxygenation, 54 male and 38 female subjects were exposed to 35,000 ft for 3 h while performing strenuous exercise, mild exercise, or seated rest. The subjects were monitored for venous gas emboli (VGE) with an echo-imaging system and observed for signs and symptoms of DCS.
RESULTS: Exposures involving strenuous and mild exercise resulted in higher incidence (p < 0.05) and earlier onset of symptoms (p < 0.05) of DCS than exposure at rest. Mild and strenuous exercise during exposure did not differ in incidence or rate of onset. Incidence at 30 min of exposure was 8% at rest and 23% while exercising.
CONCLUSION: The results showed that current guidelines for 35,000-ft exposures keep DCS risk below 10% at rest. Exercise, even at mild levels, greatly increases the incidence and rate of onset of DCS.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2001        PMID: 11396555

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  2 in total

1.  High-altitude decompression illness: case report and discussion.

Authors:  G Michael Allan; David Kenny
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

2.  Investigation of a cluster of decompression sickness cases following a high-altitude chamber flight.

Authors:  Nazim Ata; Erkan Karaca
Journal:  Diving Hyperb Med       Date:  2021-03-31       Impact factor: 0.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.